In glioblastoma tumors, different combinations of driver mutations have been shown to deregulate three core signaling networks governed by receptor tyrosine kinases (RTK), p53 and Rb, respectively in both the KEGG and TCGA databases (Verhaak et al. 2010). This evidence concerns the gene TP53 and glioblastoma.